- Home
- TOMZ vs ENLV Comparison
TOMZ vs ENLV Comparison
Compare TOMZ & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- ENLV
- Stock Information
- Founded
- TOMZ 1979
- ENLV 2005
- Country
- TOMZ United States
- ENLV Israel
- Employees
- TOMZ N/A
- ENLV N/A
- Industry
- TOMZ Diversified Commercial Services
- ENLV Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- ENLV Health Care
- Exchange
- TOMZ Nasdaq
- ENLV Nasdaq
- Market Cap
- TOMZ 22.6M
- ENLV 23.7M
- IPO Year
- TOMZ N/A
- ENLV 1995
- Fundamental
- Price
- TOMZ $0.98
- ENLV $1.42
- Analyst Decision
- TOMZ Strong Buy
- ENLV Strong Buy
- Analyst Count
- TOMZ 1
- ENLV 2
- Target Price
- TOMZ $3.50
- ENLV $10.00
- AVG Volume (30 Days)
- TOMZ 25.5K
- ENLV 168.1K
- Earning Date
- TOMZ 08-04-2025
- ENLV 08-29-2025
- Dividend Yield
- TOMZ N/A
- ENLV N/A
- EPS Growth
- TOMZ N/A
- ENLV N/A
- EPS
- TOMZ N/A
- ENLV N/A
- Revenue
- TOMZ $8,201,313.00
- ENLV N/A
- Revenue This Year
- TOMZ $3.66
- ENLV N/A
- Revenue Next Year
- TOMZ $139.63
- ENLV N/A
- P/E Ratio
- TOMZ N/A
- ENLV N/A
- Revenue Growth
- TOMZ 19.09
- ENLV N/A
- 52 Week Low
- TOMZ $0.60
- ENLV $0.81
- 52 Week High
- TOMZ $1.50
- ENLV $1.76
- Technical
- Relative Strength Index (RSI)
- TOMZ 48.29
- ENLV 70.40
- Support Level
- TOMZ $0.91
- ENLV $1.12
- Resistance Level
- TOMZ $1.01
- ENLV $1.32
- Average True Range (ATR)
- TOMZ 0.04
- ENLV 0.09
- MACD
- TOMZ -0.00
- ENLV 0.00
- Stochastic Oscillator
- TOMZ 58.25
- ENLV 93.75
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.